State Street’s Usana Health Sciences USNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.33M | Buy |
248,035
+8,858
| +4% | +$176K | ﹤0.01% | 3017 |
|
|
2025
Q4 | $4.7M | Sell |
239,177
-188,316
| -44% | -$3.91M | ﹤0.01% | 3024 |
|
|
2025
Q3 | $11.8M | Buy |
427,493
+1,149
| +0.3% | +$35.4K | ﹤0.01% | 2555 |
|
|
2025
Q2 | $13M | Sell |
426,344
-25,022
| -6% | -$711K | ﹤0.01% | 2435 |
|
|
2025
Q1 | $12.2M | Buy |
451,366
+173
| +0% | +$5.48K | ﹤0.01% | 2405 |
|
|
2024
Q4 | $16.2M | Buy |
451,193
+16,029
| +4% | +$599K | ﹤0.01% | 2334 |
|
|
2024
Q3 | $16.5M | Buy |
435,164
+2,782
| +0.6% | +$114K | ﹤0.01% | 2329 |
|
|
2024
Q2 | $19.6M | Sell |
432,382
-9,428
| -2% | -$434K | ﹤0.01% | 2184 |
|
|
2024
Q1 | $21.4M | Buy |
441,810
+4,100
| +0.9% | +$201K | ﹤0.01% | 2164 |
|
|
2023
Q4 | $23.5M | Buy |
437,710
+9,734
| +2% | +$492K | ﹤0.01% | 2124 |
|
|
2023
Q3 | $25.1M | Buy |
427,976
+101
| +0% | +$6.32K | ﹤0.01% | 2030 |
|
|
2023
Q2 | $27M | Buy |
427,875
+163
| +0% | +$10.4K | ﹤0.01% | 2055 |
|
|
2023
Q1 | $26.9M | Buy |
427,712
+2,431
| +0.6% | +$145K | ﹤0.01% | 2022 |
|
|
2022
Q4 | $22.6M | Buy |
425,281
+32,957
| +8% | +$1.79M | ﹤0.01% | 2158 |
|
|
2022
Q3 | $22M | Buy |
392,324
+6,381
| +2% | +$422K | ﹤0.01% | 2146 |
|
|
2022
Q2 | $27.9M | Sell |
385,943
-934
| -0.2% | -$69.6K | ﹤0.01% | 2007 |
|
|
2022
Q1 | $30.7M | Buy |
386,877
+6,817
| +2% | +$615K | ﹤0.01% | 2086 |
|
|
2021
Q4 | $38.5M | Sell |
380,060
-1,338
| -0.4% | -$133K | ﹤0.01% | 1994 |
|
|
2021
Q3 | $35.2M | Buy |
381,398
+6,340
| +2% | +$610K | ﹤0.01% | 2065 |
|
|
2021
Q2 | $38.4M | Buy |
375,058
+12,701
| +4% | +$1.28M | ﹤0.01% | 2046 |
|
|
2021
Q1 | $35.4M | Buy |
362,357
+4,997
| +1% | +$455K | ﹤0.01% | 1993 |
|
|
2020
Q4 | $27.6M | Sell |
357,360
-22,858
| -6% | -$1.77M | ﹤0.01% | 2032 |
|
|
2020
Q3 | $28M | Sell |
380,218
-20,565
| -5% | -$1.65M | ﹤0.01% | 1833 |
|
|
2020
Q2 | $29.4M | Sell |
400,783
-21,762
| -5% | -$1.71M | ﹤0.01% | 1801 |
|
|
2020
Q1 | $24.4M | Buy |
422,545
+24,746
| +6% | +$1.72M | ﹤0.01% | 1721 |
|
|
2019
Q4 | $31.2M | Buy |
397,799
+14,507
| +4% | +$1.07M | ﹤0.01% | 1832 |
|
|
2019
Q3 | $26.2M | Sell |
383,292
-11,359
| -3% | -$763K | ﹤0.01% | 1885 |
|
|
2019
Q2 | $31.3M | Buy |
394,651
+124,230
| +46% | +$9.85M | ﹤0.01% | 1796 |
|
|
2019
Q1 | $22.7M | Buy |
270,421
+5,793
| +2% | +$605K | ﹤0.01% | 1955 |
|
|
2018
Q4 | $31.2M | Sell |
264,628
-1,846
| -0.7% | -$213K | ﹤0.01% | 1663 |
|
|
2018
Q3 | $32.1M | Buy |
266,474
+12,908
| +5% | +$1.6M | ﹤0.01% | 1841 |
|
|
2018
Q2 | $29.2M | Buy |
253,566
+24,491
| +11% | +$2.68M | ﹤0.01% | 1869 |
|
|
2018
Q1 | $19.7M | Sell |
229,075
-23,664
| -9% | -$1.83M | ﹤0.01% | 2063 |
|
|
2017
Q4 | $18.7M | Buy |
252,739
+34,671
| +16% | +$2.32M | ﹤0.01% | 2090 |
|
|
2017
Q3 | $12.6M | Buy |
218,068
+9,075
| +4% | +$536K | ﹤0.01% | 2329 |
|
|
2017
Q2 | $13.4M | Buy |
208,993
+14,353
| +7% | +$884K | ﹤0.01% | 2246 |
|
|
2017
Q1 | $11.2M | Buy |
194,640
+3,802
| +2% | +$227K | ﹤0.01% | 2310 |
|
|
2016
Q4 | $11.7M | Buy |
190,838
+4,022
| +2% | +$262K | ﹤0.01% | 2250 |
|
|
2016
Q3 | $12.9M | Buy |
186,816
+3,326
| +2% | +$219K | ﹤0.01% | 2037 |
|
|
2016
Q2 | $10.2M | Sell |
183,490
-7,580
| -4% | -$457K | ﹤0.01% | 2214 |
|
|
2016
Q1 | $11.6M | Buy |
191,070
+1,784
| +0.9% | +$105K | ﹤0.01% | 2090 |
|
|
2015
Q4 | $12.1M | Sell |
189,286
-1,320
| -0.7% | -$85.6K | ﹤0.01% | 2076 |
|
|
2015
Q3 | $12.8M | Sell |
190,606
-5,640
| -3% | -$399K | ﹤0.01% | 2033 |
|
|
2015
Q2 | $13.4M | Buy |
196,246
+5,098
| +3% | +$324K | ﹤0.01% | 2107 |
|
|
2015
Q1 | $10.6M | Sell |
191,148
-144
| -0.1% | -$7.38K | ﹤0.01% | 2189 |
|
|
2014
Q4 | $9.82M | Sell |
191,292
-4,930
| -3% | -$242K | ﹤0.01% | 2227 |
|
|
2014
Q3 | $7.23M | Sell |
196,222
-7,894
| -4% | -$285K | ﹤0.01% | 2346 |
|
|
2014
Q2 | $7.98M | Sell |
204,116
-7,224
| -3% | -$268K | ﹤0.01% | 2342 |
|
|
2014
Q1 | $7.96M | Sell |
211,340
-6,328
| -3% | -$221K | ﹤0.01% | 2320 |
|
|
2013
Q4 | $8.23M | Sell |
217,668
-4,204
| -2% | -$161K | ﹤0.01% | 2291 |
|
|
2013
Q3 | $9.63M | Buy |
221,872
+2,162
| +1% | +$86.8K | ﹤0.01% | 2148 |
|
|
2013
Q2 | $7.95M | Buy |
+219,710
| New | +$6.68M | ﹤0.01% | 2189 |
|
Other funds holding USNA
NCM
VCM
VPM
State Street's USNA Position: Q1 2026 in Review
State Street increased its Usana Health Sciences (USNA) stake by 3.7% in Q1 2026, buying an estimated $176K and bringing the position to 248,035 shares worth $4.33M. The position accounts for ﹤0.01% of the portfolio, ranked #3017.
State Street first reported a position in USNA in Q2 2013 and has held it in 52 quarters since. The position peaked at $38.5M in Q4 2021. 139 funds tracked by Wall St. Rank hold USNA as of Q1 2026.
- State Street held 248,035 shares of Usana Health Sciences worth $4.33M as of Q1 2026.
- State Street bought 8,858 Usana Health Sciences shares in Q1 2026, an estimated $176K.
- Usana Health Sciences made up ﹤0.01% of State Street's portfolio in Q1 2026, its #3017 holding.
- State Street first reported a position in Usana Health Sciences in Q2 2013 and has held it in 52 quarters since.
- State Street's Usana Health Sciences position peaked at $38.5M in Q4 2021.
- 139 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2026.
Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.